Report Categories Report Categories

Report Categories

industry Category

All

Total: 5 records, 1 pages

Global Coronary Drug-Coated Balloon Supply, Demand and Key Producers, 2024-2030

date 24 Feb 2024

date Medical Devices & Consumables

new_biaoQian Coronary Drug-Coated Balloon

The global Coronary Drug-Coated Balloon market size is expected to reach $ 1216 million by 2030, rising at a market growth of 15.1% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Coronary Drug-Coated Balloon Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 05 Jan 2024

date Medical Devices & Consumables

new_biaoQian Coronary Drug-Coated Balloon

According to our (Global Info Research) latest study, the global Coronary Drug-Coated Balloon market size was valued at USD 454.1 million in 2023 and is forecast to a readjusted size of USD 1216 million by 2030 with a CAGR of 15.1% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Coronary Drug-Coated Balloon Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 06 Feb 2023

date Medical Devices & Consumables

new_biaoQian Coronary Drug-Coated Balloon

The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.

USD3480.00

Add To Cart

Add To Cart

Global Coronary Drug-Coated Balloon Supply, Demand and Key Producers, 2023-2029

date 03 Feb 2023

date Medical Devices & Consumables

new_biaoQian Coronary Drug-Coated Balloon

The global Coronary Drug-Coated Balloon market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

Global Coronary Drug-Coated Balloon Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 09 Sep 2022

date Medical Devices & Consumables

new_biaoQian coronary drug coated balloon

The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.

USD3480.00

Add To Cart

Add To Cart

industry 24 Feb 2024

industry Medical Devices & Consumables

new_biaoQian Coronary Drug-Coated Balloon

The global Coronary Drug-Coated Balloon market size is expected to reach $ 1216 million by 2030, rising at a market growth of 15.1% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 05 Jan 2024

industry Medical Devices & Consumables

new_biaoQian Coronary Drug-Coated Balloon

According to our (Global Info Research) latest study, the global Coronary Drug-Coated Balloon market size was valued at USD 454.1 million in 2023 and is forecast to a readjusted size of USD 1216 million by 2030 with a CAGR of 15.1% during review period.

USD3480.00

addToCart

Add To Cart

industry 06 Feb 2023

industry Medical Devices & Consumables

new_biaoQian Coronary Drug-Coated Balloon

The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.

USD3480.00

addToCart

Add To Cart

industry 03 Feb 2023

industry Medical Devices & Consumables

new_biaoQian Coronary Drug-Coated Balloon

The global Coronary Drug-Coated Balloon market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart

industry 09 Sep 2022

industry Medical Devices & Consumables

new_biaoQian coronary drug coated balloon

The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.

USD3480.00

addToCart

Add To Cart